Quest Diagnostics Director Vicky B. Gregg Acquires 63 Shares via Dividend Reinvestment Plan
QUEST DIAGNOSTICS INC
Subscribe to track DGX
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Quest Diagnostics Inc ($DGX) - Form 4 Filing Update
Insider: Vicky B. Gregg (Director) Transaction Date: 2026-10-21 Type: Acquisition (DRIP / Dividend Reinvestment) Shares: 63 @ $235.94 Total Value: $14,864.16 Post-Transaction Ownership: 18,449 shares (Direct) Significance: Low (Routine Dividend Reinvestment)
Comprehensive Analysis
Executive Summary
On October 23, 2026, Quest Diagnostics Inc ($DGX) filed a Form 4 disclosing that Director Vicky B. Gregg acquired 63 shares of common stock on October 21, 2026. The transaction was executed at a price of $235.939 per share for an aggregate transaction value of approximately $14,864.16.
Transaction Details
- Security: Common Stock
- Transaction Code: A (Acquisition via broker dividend reinvestment plan)
- Shares Acquired: 63
- Price Per Share: $235.939
- Total Investment: $14,864.16
- Ownership Post-Transaction: 18,449 direct shares
- Filing Note: As specified in the footnote, the shares were acquired under a dividend reinvestment plan administered by the insider's broker. While eligible for deferred reporting on Form 5 under Rule 16a-6, the reporting person elected early disclosure on Form 4.
Significance & Market Context
The trading significance of this transaction is Low. Automatic dividend reinvestments reflect regular administrative acquisitions rather than active, discretionary open-market buying decisions.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.